HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ablation of ferroptosis regulator glutathione peroxidase 4 in forebrain neurons promotes cognitive impairment and neurodegeneration.

Abstract
Synaptic loss and neuron death are the underlying cause of neurodegenerative diseases such as Alzheimer's disease (AD); however, the modalities of cell death in those diseases remain unclear. Ferroptosis, a newly identified oxidative cell death mechanism triggered by massive lipid peroxidation, is implicated in the degeneration of neurons populations such as spinal motor neurons and midbrain neurons. Here, we investigated whether neurons in forebrain regions (cerebral cortex and hippocampus) that are severely afflicted in AD patients might be vulnerable to ferroptosis. To this end, we generated Gpx4BIKO mouse, a mouse model with conditional deletion in forebrain neurons of glutathione peroxidase 4 (Gpx4), a key regulator of ferroptosis, and showed that treatment with tamoxifen led to deletion of Gpx4 primarily in forebrain neurons of adult Gpx4BIKO mice. Starting at 12 weeks after tamoxifen treatment, Gpx4BIKO mice exhibited significant deficits in spatial learning and memory function versus Control mice as determined by the Morris water maze task. Further examinations revealed that the cognitively impaired Gpx4BIKO mice exhibited hippocampal neurodegeneration. Notably, markers associated with ferroptosis, such as elevated lipid peroxidation, ERK activation and augmented neuroinflammation, were observed in Gpx4BIKO mice. We also showed that Gpx4BIKO mice fed a diet deficient in vitamin E, a lipid soluble antioxidant with anti-ferroptosis activity, had an expedited rate of hippocampal neurodegeneration and behavior dysfunction, and that treatment with a small-molecule ferroptosis inhibitor ameliorated neurodegeneration in those mice. Taken together, our results indicate that forebrain neurons are susceptible to ferroptosis, suggesting that ferroptosis may be an important neurodegenerative mechanism in diseases such as AD.
AuthorsWilliam Sealy Hambright, Rene Solano Fonseca, Liuji Chen, Ren Na, Qitao Ran
JournalRedox biology (Redox Biol) Vol. 12 Pg. 8-17 (08 2017) ISSN: 2213-2317 [Electronic] Netherlands
PMID28212525 (Publication Type: Journal Article)
CopyrightCopyright © 2017. Published by Elsevier B.V.
Chemical References
  • Tamoxifen
  • Phospholipid Hydroperoxide Glutathione Peroxidase
  • Glutathione Peroxidase
  • glutathione peroxidase 4, mouse
Topics
  • Animals
  • Cell Death
  • Cognitive Dysfunction (chemically induced, genetics, metabolism)
  • Disease Models, Animal
  • Gene Knockout Techniques
  • Glutathione Peroxidase (genetics, metabolism)
  • Lipid Peroxidation
  • Maze Learning
  • Mice
  • Neurodegenerative Diseases (chemically induced, genetics, metabolism)
  • Neurons (metabolism)
  • Oxidation-Reduction
  • Phospholipid Hydroperoxide Glutathione Peroxidase
  • Prosencephalon (cytology, metabolism)
  • Tamoxifen (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: